Related donor Adenovirus (ADV) specific cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered intravenously in in children, adolescents and young adults with refractory ADV infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ transplant. Funding Source: FDA OOPD
Adenovirus, Primary Immune Deficiency Disorder
Related donor Adenovirus (ADV) specific cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered intravenously in in children, adolescents and young adults with refractory ADV infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ transplant. Funding Source: FDA OOPD
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
-
Children's Hospital Los Angeles, Los Angeles, California, United States, 90027
University of California San Francisco, San Francisco, California, United States, 94158
Children's Hospital of Colorado, Aurora, Colorado, United States, 80045
University of Colorado Denver, Aurora, Colorado, United States, 80045
Indiana University, Indianapolis, Indiana, United States, 46202
Johns Hopkins, Baltimore, Maryland, United States, 21287
Washington University, Saint Louis, Missouri, United States, 63130
Nationwide Children's Hosptial, Columbus, Ohio, United States, 43205
Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104
Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States, 53226
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
1 Month to 79 Years
ALL
No
New York Medical College,
Mitchell Cairo, MD, PRINCIPAL_INVESTIGATOR, New York Medical College
2026-12-31